Literature DB >> 19812300

Expression and distribution of NADPH oxidase isoforms in human myometrium--role in angiotensin II-induced hypertrophy.

Xiao-Lan Cui1, Baojun Chang, Leslie Myatt.   

Abstract

The renin-angiotensin system is upregulated in pregnant women and may play a role in myometrial hypertrophy during pregnancy. We examined whether angiotensin II could induce myometrial protein synthesis as determined by (3)H-leucine incorporation in an immortalized human myometrial smooth muscle cell line (ULTR cells). The effects of angiotensin II were mediated by NADPH oxidase because diphenylene iodonium abolished angiotensin II-induced protein synthesis. We investigated gene expression and cellular localization of NADPH oxidase isoforms in ULTR cells and confirmed expression of NOX1, NOX4, and NOX5 in myometrial tissue. Angiotensin II induced a cellular redistribution and upregulation of NOX5 protein without altering NOX1 and NOX4 expression. It seems the effect of angiotensin II relies on the type 1 receptor (AT1), because losartan significantly blocked angiotensin II-induced increase in (3)H-leucine incorporation. We conclude that NADPH oxidase mediates angiotensin II-stimulated protein synthesis downstream of AT1 in myometrium smooth muscle cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19812300      PMCID: PMC2809224          DOI: 10.1095/biolreprod.109.080275

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  68 in total

1.  A novel superoxide-producing NAD(P)H oxidase in kidney.

Authors:  A Shiose; J Kuroda; K Tsuruya; M Hirai; H Hirakata; S Naito; M Hattori; Y Sakaki; H Sumimoto
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

2.  A new superoxide-generating oxidase in murine osteoclasts.

Authors:  S Yang; P Madyastha; S Bingel; W Ries; L Key
Journal:  J Biol Chem       Date:  2000-11-29       Impact factor: 5.157

3.  Sex steroid modulation of AT2 receptors in human myometrium.

Authors:  R Mancina; T Susini; A Renzetti; G Forti; E Razzoli; M Serio; M Maggi
Journal:  J Clin Endocrinol Metab       Date:  1996-05       Impact factor: 5.958

4.  Tissue specific expression of vascular smooth muscle angiotensin II receptor subtypes during ovine pregnancy.

Authors:  B E Cox; C R Rosenfeld; J E Kalinyak; R R Magness; P W Shaul
Journal:  Am J Physiol       Date:  1996-07

5.  Novel gp91(phox) homologues in vascular smooth muscle cells : nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways.

Authors:  B Lassègue; D Sorescu; K Szöcs; Q Yin; M Akers; Y Zhang; S L Grant; J D Lambeth; K K Griendling
Journal:  Circ Res       Date:  2001-05-11       Impact factor: 17.367

6.  Type 2 angiotensin II receptor is expressed in human myometrium and uterine leiomyoma and is down-regulated during pregnancy.

Authors:  T Matsumoto; N Sagawa; M Mukoyama; I Tanaka; H Itoh; M Goto; H Itoh; M Horiuchi; V J Dzau; T Mori; K Nakao
Journal:  J Clin Endocrinol Metab       Date:  1996-12       Impact factor: 5.958

7.  Angiotensin II induces p67phox mRNA expression and NADPH oxidase superoxide generation in rabbit aortic adventitial fibroblasts.

Authors:  P J Pagano; S J Chanock; D A Siwik; W S Colucci; J K Clark
Journal:  Hypertension       Date:  1998-08       Impact factor: 10.190

Review 8.  Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases.

Authors:  H Matsubara
Journal:  Circ Res       Date:  1998 Dec 14-28       Impact factor: 17.367

9.  Angiotensin II receptor characteristics and subtype expression in uterine arteries and myometrium during pregnancy.

Authors:  B E Cox; R A Word; C R Rosenfeld
Journal:  J Clin Endocrinol Metab       Date:  1996-01       Impact factor: 5.958

10.  p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells.

Authors:  M Ushio-Fukai; A M Zafari; T Fukui; N Ishizaka; K K Griendling
Journal:  J Biol Chem       Date:  1996-09-20       Impact factor: 5.157

View more
  5 in total

Review 1.  Nox NADPH oxidases and the endoplasmic reticulum.

Authors:  Francisco R M Laurindo; Thaís L S Araujo; Thalita B Abrahão
Journal:  Antioxid Redox Signal       Date:  2014-02-26       Impact factor: 8.401

2.  Characterization of NADPH oxidase 5 expression in human tumors and tumor cell lines with a novel mouse monoclonal antibody.

Authors:  Smitha Antony; Yongzhong Wu; Stephen M Hewitt; Miriam R Anver; Donna Butcher; Guojian Jiang; Jennifer L Meitzler; Han Liu; Agnes Juhasz; Jiamo Lu; Krishnendu K Roy; James H Doroshow
Journal:  Free Radic Biol Med       Date:  2013-07-11       Impact factor: 7.376

3.  Upregulation of intermediate-conductance Ca2+-activated K+ channels (KCNN4) in porcine coronary smooth muscle requires NADPH oxidase 5 (NOX5).

Authors:  Hope K A Gole; Darla L Tharp; Douglas K Bowles
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

Review 4.  NADPH oxidase in brain injury and neurodegenerative disorders.

Authors:  Merry W Ma; Jing Wang; Quanguang Zhang; Ruimin Wang; Krishnan M Dhandapani; Ratna K Vadlamudi; Darrell W Brann
Journal:  Mol Neurodegener       Date:  2017-01-17       Impact factor: 14.195

5.  Fetal-maternal interface impedance parallels local NADPH oxidase related superoxide production.

Authors:  L Guedes-Martins; E Silva; A R Gaio; J Saraiva; A I Soares; J Afonso; F Macedo; H Almeida
Journal:  Redox Biol       Date:  2015-04-20       Impact factor: 11.799

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.